Richard Miller

Company: Kymera Therapeutics
Job title: Executive Director, Lead Discovery
Seminars:
Exploiting Tissue Sparing E3 Ligases for Next Generation TPD Medicines 8:00 am
Highlighting the promises and challenges of exploiting tissue sparing E3 ligases Pinpointing LED selection criteria for novel E3 ligases for TPD application Showcasing tissue sparing E3 ligases to unlock clinically validated targets Read more
day: Day 2 AM